462 related articles for article (PubMed ID: 17684761)
1. Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors.
Klöppel G; Rindi G; Anlauf M; Perren A; Komminoth P
Virchows Arch; 2007 Aug; 451 Suppl 1():S9-27. PubMed ID: 17684761
[TBL] [Abstract][Full Text] [Related]
2. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms.
Klöppel G
Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S1-16. PubMed ID: 22005112
[TBL] [Abstract][Full Text] [Related]
3. [Trends in gastroenteropancreatic neuroendocrine tumors].
Kajiwara H; Osamura Y
Nihon Geka Gakkai Zasshi; 2008 May; 109(3):123-7. PubMed ID: 18536314
[TBL] [Abstract][Full Text] [Related]
4. Lung and digestive neuroendocrine neoplasms. From WHO classification to biomarker screening: Which perspectives?
Scoazec JY
Ann Endocrinol (Paris); 2019 Jun; 80(3):163-165. PubMed ID: 31064659
[TBL] [Abstract][Full Text] [Related]
5. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.
Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O
Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616
[TBL] [Abstract][Full Text] [Related]
6. Incidence and clinical characteristics of gastroenteropancreatic neuroendocrine tumor in Korea: a single-center experience.
Lim CH; Lee IS; Jun BY; Kim JS; Cho YK; Park JM; Roh SY; Lee MA; Kim SW; Choi MG
Korean J Intern Med; 2017 May; 32(3):452-458. PubMed ID: 28490723
[TBL] [Abstract][Full Text] [Related]
7. Loss of nuclear p27 expression and its prognostic role in relation to cyclin E and p53 mutation in gastroenteropancreatic neuroendocrine tumors.
Grabowski P; Schrader J; Wagner J; Hörsch D; Arnold R; Arnold CN; Georgieva I; Stein H; Zeitz M; Daniel PT; Sturm I
Clin Cancer Res; 2008 Nov; 14(22):7378-84. PubMed ID: 19010853
[TBL] [Abstract][Full Text] [Related]
8. Aspects regarding nomenclature, classification and pathology of neuroendocrine neoplasms of the digestive system - a review.
Păun I; Becheanu G; Costin AI; Constantin VD; Mihai GM; Radu L; Iovan L; Vârcuş F
Rom J Morphol Embryol; 2018; 59(3):673-678. PubMed ID: 30534804
[TBL] [Abstract][Full Text] [Related]
9. Digestive neuroendocrine tumors: reclassifying of 26 cases according to 2010 who classification.
Chaabane A; M'sakni I; Laabidi B; Bougrine F; Bouziani A
Tunis Med; 2016 Oct; 94(8-9):580-586. PubMed ID: 28685792
[TBL] [Abstract][Full Text] [Related]
10. Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters.
Niederle MB; Hackl M; Kaserer K; Niederle B
Endocr Relat Cancer; 2010 Dec; 17(4):909-18. PubMed ID: 20702725
[TBL] [Abstract][Full Text] [Related]
11. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.
Pape UF; Jann H; Müller-Nordhorn J; Bockelbrink A; Berndt U; Willich SN; Koch M; Röcken C; Rindi G; Wiedenmann B
Cancer; 2008 Jul; 113(2):256-65. PubMed ID: 18506737
[TBL] [Abstract][Full Text] [Related]
12. [Neuroendocrine tumors of digestive system: morphologic spectrum and cell proliferation (Ki67 index)].
Delektorskaia VV; Kushliskiĭ NE
Vestn Ross Akad Med Nauk; 2013; (5):28-37. PubMed ID: 24000665
[TBL] [Abstract][Full Text] [Related]
13. [Neuroendocrine tumours of the alimentary tract--history and at present].
Mandys V
Cesk Patol; 2009 Jul; 45(3):57-63. PubMed ID: 19764158
[TBL] [Abstract][Full Text] [Related]
14. Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement.
Coriat R; Walter T; Terris B; Couvelard A; Ruszniewski P
Oncologist; 2016 Oct; 21(10):1191-1199. PubMed ID: 27401895
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD133 in neuroendocrine neoplasms of the digestive tract: a detailed immunohistochemical analysis.
Mia-Jan K; Munkhdelger J; Lee MR; Ji SY; Kang TY; Choi E; Cho MY
Tohoku J Exp Med; 2013 Apr; 229(4):301-9. PubMed ID: 23615455
[TBL] [Abstract][Full Text] [Related]
16. [Classification of gastro-entero-pancreatic neuroendocrine tumors].
Perren A; Schmitt A; Komminoth P; Pavel M
Radiologe; 2009 Mar; 49(3):198-205. PubMed ID: 19224191
[TBL] [Abstract][Full Text] [Related]
17. [Pathology of neuroendocrine neoplasms].
Anlauf M; Gerlach P; Schott M; Raffel A; Krausch M; Knoefel WT; Pavel M; Klöppel G
Chirurg; 2011 Jul; 82(7):567-73. PubMed ID: 21487814
[TBL] [Abstract][Full Text] [Related]
18. Gastroenteropancreatic (neuro)endocrine neoplasms: the histology report.
Rindi G; Bordi C; La Rosa S; Solcia E; Delle Fave G; ;
Dig Liver Dis; 2011 Mar; 43 Suppl 4():S356-60. PubMed ID: 21459341
[TBL] [Abstract][Full Text] [Related]
19. Endocrine tumors of the gut and pancreas tumor biology and classification.
Rindi G; Klöppel G
Neuroendocrinology; 2004; 80 Suppl 1():12-5. PubMed ID: 15477709
[TBL] [Abstract][Full Text] [Related]
20. The Problem of High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Beyond.
Sorbye H; Baudin E; Perren A
Endocrinol Metab Clin North Am; 2018 Sep; 47(3):683-698. PubMed ID: 30098724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
